GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Medical Solutions Group PLC (FRA:AQA) » Definitions » EV-to-EBIT

Advanced Medical Solutions Group (FRA:AQA) EV-to-EBIT : 18.60 (As of May. 20, 2024)


View and export this data going back to . Start your Free Trial

What is Advanced Medical Solutions Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Advanced Medical Solutions Group's Enterprise Value is €466.2 Mil. Advanced Medical Solutions Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €25.1 Mil. Therefore, Advanced Medical Solutions Group's EV-to-EBIT for today is 18.60.

The historical rank and industry rank for Advanced Medical Solutions Group's EV-to-EBIT or its related term are showing as below:

FRA:AQA' s EV-to-EBIT Range Over the Past 10 Years
Min: 12.41   Med: 20.47   Max: 65.74
Current: 18.56

During the past 13 years, the highest EV-to-EBIT of Advanced Medical Solutions Group was 65.74. The lowest was 12.41. And the median was 20.47.

FRA:AQA's EV-to-EBIT is ranked better than
54.27% of 457 companies
in the Medical Devices & Instruments industry
Industry Median: 20.37 vs FRA:AQA: 18.56

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Advanced Medical Solutions Group's Enterprise Value for the quarter that ended in Dec. 2023 was €459.0 Mil. Advanced Medical Solutions Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €25.1 Mil. Advanced Medical Solutions Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 5.46%.


Advanced Medical Solutions Group EV-to-EBIT Historical Data

The historical data trend for Advanced Medical Solutions Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Medical Solutions Group EV-to-EBIT Chart

Advanced Medical Solutions Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.56 45.87 29.84 18.62 18.26

Advanced Medical Solutions Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.84 - 18.62 - 18.26

Competitive Comparison of Advanced Medical Solutions Group's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Medical Solutions Group's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Advanced Medical Solutions Group's EV-to-EBIT falls into.



Advanced Medical Solutions Group EV-to-EBIT Calculation

Advanced Medical Solutions Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=466.247/25.063
=18.60

Advanced Medical Solutions Group's current Enterprise Value is €466.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Advanced Medical Solutions Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €25.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Advanced Medical Solutions Group  (FRA:AQA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Advanced Medical Solutions Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=25.063/458.96718
=5.46 %

Advanced Medical Solutions Group's Enterprise Value for the quarter that ended in Dec. 2023 was €459.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Advanced Medical Solutions Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €25.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Advanced Medical Solutions Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Advanced Medical Solutions Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced Medical Solutions Group (FRA:AQA) Business Description

Traded in Other Exchanges
Address
Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT
U.K.-based Advanced Medical Solutions was founded in 1991 to design, develop, and manufacture advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The firm derives approximately 60% of total revenue from branded products, with nonbranded contributing 40%.

Advanced Medical Solutions Group (FRA:AQA) Headlines

No Headlines